Oscar Health, Inc. (OSCR) News
Follow Oscar Health, Inc. (OSCR) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 18 public stories across 9 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Oscar Health Reports Third-Quarter 2026 Results, Raises Full-Year Outlook
EQUITY | Nov 05, 2026, 11:17 AM UTC
M
Oscar Health Reports Q3 Net Income of $167.281 Million
EARNINGS | Nov 05, 2026, 11:14 AM UTC
M
Oscar Health Posts Q3 EPS of $0.49
Oscar Health reported Q3 EPS of $0.49, versus a FactSet estimate of a $0.14 loss.
EQUITY | Nov 05, 2026, 11:06 AM UTC
M
Oscar Health Q3 revenue reaches $5,139.298 million
Q3 revenue was $5,139.298 million versus an IBES estimate of $4,723 million.
EQUITY | Nov 05, 2026, 11:02 AM UTC
M
Oscar Health Q3 Adjusted EBITDA $206.852 Million vs. IBES Estimate of -$21.8 Million
EARNINGS | Nov 05, 2026, 11:02 AM UTC
H
Humana Reaffirms FY26 Adjusted EPS Guidance Of At Least $9; Exceeding Goal Of Top Quartile Results In 2027 Medicare Advantage Star Ratings; Expects 2028 Benefit For One-Time Investments And Return To Shareholders
Humana affirms its guidance of at least $9.00 in adjusted earnings per common share ("Adjusted EPS"), for the year ending December 31, 2026 ("FY 2026"). This guidance is consistent with the guidance issued in Humana’s pr
LIVE | Oct 09, 2026, 10:11 AM UTC
H
Oscar Health Q2 2026 Earnings Call: Complete Transcript
Oscar Health (NYSE: OSCR ) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you APIs. For real-time access to our entire catalog,
LIVE | Oct 05, 2026, 11:57 AM UTC
L
OSCR - Oscar Health Announces Thrive Capital’s Completion of Oscar Health Common Stock Distribution to its Limited Partners
OSCR - Oscar Health Announces Thrive Capital’s Completion of Oscar Health Common Stock Distribution to its Limited Partners
EQUITY | Sep 19, 2026, 12:33 AM UTC
M
Oscar Health raises 2026 guidance, shares rise
Oscar Health lifted its full-year 2026 earnings from operations target to $600 million-$800 million from $500 million-$700 million and trimmed its medical loss ratio outlook to 81.0%-82.0%. Analysts also raised price tar
EARNINGS | Sep 17, 2026, 04:08 PM UTC
L
Baird raises Oscar Health price target to $33
Baird raised its price target for Oscar Health to $33.00 per share from $27.00, according to Benzinga ratings actions.
EQUITY | Sep 17, 2026, 12:20 PM UTC
H
Oscar Health Reaffirms Raises FY26 Earnings From Operations Guidance From $500M-$700M To $600M-$800M; Reaffirms FY26 Sales Guidance Of $18.7B-$19B
As previously announced, Oscar Health, Inc. (the "Company" or "Oscar") will host its 2026 Investor Day on Wednesday, September 16, 2026, beginning at 9:00 a.m. Eastern Time. At the event, the Company will discuss its str
LIVE | Sep 16, 2026, 10:08 AM UTC
L
Ten financial stocks combining strong revenue growth with attractive valuations
Financials stocks remain a focal point for investors as mortgage services, digital payments, and alternative asset management continue to drive growth across the sector.While many financial companies trade at premium val
EQUITY | Sep 09, 2026, 05:21 PM UTC
L
Oscar Health Raises Outlook But Warns CMS Membership Churn Will Pick Up
Oscar Health Inc. (NYSE: OSCR ) stock fell nearly 10% on Thursday despite the health insurer reporting second-quarter revenue and earnings that topped Wall Street expectations and reaffirming its full-year revenue outloo
EARNINGS | Aug 06, 2026, 04:31 PM UTC
H
OSCR Raises FY26 guidance
OSCR Raises FY26 guidance
EQUITY | Aug 06, 2026, 10:07 AM UTC
L
Oscar Health Reports EPS $1.10
Oscar Health beats EPS estimates
EARNINGS | Aug 06, 2026, 10:03 AM UTC
L
Oscar Health Affirms FY2026 Sales Guidance of $18.700B-$19.000B vs $18.623B Est
Oscar Health (NYSE: OSCR ) affirms FY2026 sales outlook from $18.700 billion-$19.000 billion to $18.700 billion-$19.000 billion vs $18.623 billion estimate.
EARNINGS | Aug 06, 2026, 10:02 AM UTC
H
Elevance Health's Small Outlook Boost Disappoints, Stock Sinks
Elevance Health Inc. (NYSE: ELV ) on Wednesday reported second-quarter results that topped Wall Street estimates and raised its full-year adjusted earnings and operating cash flow guidance, supported by higher premium yi
EARNINGS | Jul 15, 2026, 02:22 PM UTC
L
MOH -6% CNC -4% OSCR -1.5% premarket after ELV results, -7.5%
MOH -6% CNC -4% OSCR -1.5% premarket after ELV results, -7.5%
EQUITY | Jul 15, 2026, 11:20 AM UTC